Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 39 references it cites were found in a registry or an index.

Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis

Open access

Abstract

There is a growing interest in patient-reported outcomes (PROs) in rheumatology, which goes with a global trend for more ‘patient-centred care’. This review considers the use of PROs in trials, including their strengths and limitations. In rheumatoid arthritis (RA) trials, the most frequently used PROs to assess treatments include pain, patient global assessment, assessment of functional status, but also health-related quality of life and less commonly fatigue. Other aspects of importance for patients, such as sleep, psychological well-being or ability to cope, are rarely assessed. PROs as outcome measures in RA trials have strengths as well as limitations. PROs have face validity, they are reproducible and sensitive to change and they bring additional information beyond joint counts or acute phase reactants. However, their predictive validity for later outcomes has been little explored, some PROs show redundancy (they bring similar information) and, due to the apparently moderate link between some PROs such as fatigue and the disease process, the use of some PROs to inform treatment choices has been questioned. We suggest the choice of PROs for trials depends on the study objective and on the viewpoint of the stakeholder. There needs to be agreed prioritisation across all stakeholders about what is most important to collect in a trial, which is why a prioritisation and selection process is necessary. Trials in RA will continue to include PROs and their interpretation will become easier as our knowledge progresses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/rmdopen-2014-000019

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The pathway in rheumatoid arthritis and examples of some frequent outcome measures.
Figure 1 The pathway in rheumatoid arthritis and examples of some frequent outcome measures.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 1

  1. 10.1002/1529-0131(200003)43:3<506::aid-anr5>3.0.co;2-u · DOI

Cited by

See all 123

Metadata

Authors
Gossec, L., Dougados, M., & Dixon, W.
Affiliations
  • Assistance Publique – Hôpitaux de Paris (FR)
  • Inserm (FR)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
Gossec, Laure
Venue
RMD Open
Publisher
BMJ
Published
2015-04
Volume
1
Issue
1
Pages
e000019
ISSN
2056-5933 (ISSN-L)
OpenAlex
W2040963445
Cited by
115
References
39
Citations by year
2026: 4 · 2025: 9 · 2024: 8 · 2023: 6 · 2022: 12 · 2021: 14 · 2020: 15 · 2019: 15 · 2018: 11 · 2017: 14 · 2016: 7
FWCI
1.65
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • RMD Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Funders
Medical Research Council (G0902272)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
patient-reported outcomes, rheumatoid arthritis, clinical trial endpoints, patient-centered care, health-related quality of life, fatigue, pain, patient global assessment, functional status, outcome measure selection, predictive validity, stakeholder prioritization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. https://app.cochat.ai/papers/10.1136/rmdopen-2014-000019
The paper
Gossec, L., Dougados, M., & Dixon, W. (2015). Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis. RMD Open. https://doi.org/10.1136/rmdopen-2014-000019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.